Clinical Trials

Clinical trials are scientific studies designed to evaluate the effectiveness and safety of a new drug by monitoring their effects. Qurient has been conducting clinical trials in various disease indications. Additional information about our clinical trials is available at www.clinicaltrials.gov, which is a resource provided by the U.S. National Library of Medicine. For more information, please contact Qurient Co., Ltd. (+82-31-8060-1600 or clinicaltrial_info@qurient.com).

Pipeline	Condition/Disease	Phase	Link	Status	Result
Q702	Solid Tumors	1	NCT04648254	Recruiting
Q702	Esophageal Cancer Gastric Cancer Hepatocellular Cancer Cervical Cancer	1B/2	NCT05438420	Recruiting
Q901	Advanced Cancer	1/2	NCT05394103	Recruiting
Telacebec, Q203	Healthy volunteers	1	NCT02530710	Completed
Telacebec, Q203	Healthy volunteers	1	NCT02858973	Completed
Telacebec, Q203	Pulmonary Tuberculosis	2	NCT03563599	Completed	Telacebec (Q203), a New Antituberculosis Agent.
Q301	Atopic Dermatitis	2	NCT02426359	Completed	Poster: 2019 AAD annual meeting.
Q301	Atopic Dermatitis	2	NCT03571620	Completed

Pipeline	Q702
Condition/Disease	Solid Tumors
Phase	1
Link	NCT04648254
Status	Recruiting
Result

Pipeline	Q702
Condition/Disease	Esophageal Cancer Gastric Cancer Hepatocellular Cancer Cervical Cancer
Phase	1B/2
Link	NCT05438420
Status	Recruiting
Result

Pipeline	Q901
Condition/Disease	Advanced Cancer
Phase	1/2
Link	NCT05394103
Status	Recruiting
Result

Pipline	Telacebec, Q203
Condition/Disease	Healthy volunteers
Phase	1
Link	NCT02530710
Status	Completed
Result

Pipline	Telacebec, Q203
Condition/Disease	Healthy volunteers
Phase	1
Link	NCT02858973
Status	Completed
Result

Pipline	Telacebec, Q203
Condition/Disease	Pulmonary Tuberculosis
Phase	2
Link	NCT03563599
Status	Completed
Result	Telacebec (Q203), a New Antituberculosis Agent.

Pipline	Q301
Condition/Disease	Atopic Dermatitis
Phase	2
Link	NCT02426359
Status	Completed
Result	Poster: 2019 AAD annual meeting.

Pipline	Q301
Condition/Disease	Atopic Dermatitis
Phase	2
Link	NCT03571620
Status	Completed
Result

For more information about clinical trials:

Phone: +82-31-8060-1600, Monday-Friday, 9am - 6pm (KST)
Email:clinicaltrial_info@qurient.com
Web: www.clinicaltrials.gov